Are we doing better? Impact of treatment paradigm change on neovascular age-related macular degeneration treatment outcomes over the past decade. A big data analysis.
Roy Schwartz, Alasdair Warwick, Abraham Olvera-Barrios, Maria Pikoula, Aaron Y Lee, Spiros Denaxas, Paul Taylor, Catherine Egan, Usha Chakravarthy, Peck Lin Lip, others
January 2021